<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02700893</url>
  </required_header>
  <id_info>
    <org_study_id>PRETTINEO sub-study</org_study_id>
    <nct_id>NCT02700893</nct_id>
  </id_info>
  <brief_title>Cerebral NIRS Profiles During Premedication for Neonatal Intubation</brief_title>
  <official_title>Cerebral NIRS Profiles During Premedication for Neonatal Intubation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Intercommunal Creteil</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Association Clinique Thérapeutique Infantile du val de Marne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre de Recherche Clinique du CHIC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Intercommunal Creteil</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational ancillary study of the PRETTINEO study (ClinicalTrials.gov Identifier:&#xD;
      NCT01490580) which is a multicenter double blind randomized controlled trial comparing&#xD;
      &quot;atropine+propofol&quot; vs &quot;atropine+atracurium+sufentanil&quot; as a premedication prior to&#xD;
      endotracheal intubation of the neonate.&#xD;
&#xD;
      Primary outcome:&#xD;
&#xD;
        -  Cerebral desaturation defined by a rScO2 delta &gt;20% from the baseline value (before&#xD;
           premedication).&#xD;
&#xD;
        -  Variation of more than 10% of cerebral FTOE (Fractional Tissue Oxygen Extraction) during&#xD;
           premedication, calculated from rScO2 and pulse oximetry with the formula FTOE=SaO2 -&#xD;
           rScO2/SaO2 .&#xD;
&#xD;
      Hypothesis: &quot;atropine + propofol&quot; compared to &quot;atropine+atracurium+sufentanil&quot; does not&#xD;
      increase the frequency of cerebral hypoxemia.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2016</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cerebral desaturation</measure>
    <time_frame>from 1 minute before to 60 minutes after the start of premedication</time_frame>
    <description>rScO2 delta &gt;20% from the baseline value (before premedication). rScO2 recording measured by INVOS 1500C 1 minute before the first injection and at 3, 6, 9, 12, 15, 30, 45 and 60 minutes after the first drug injection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>FTOE (Fractional Tissue Oxygen Extraction)</measure>
    <time_frame>from 1 minute before to 60 minutes after the start of premedication</time_frame>
    <description>Variation of more than 10% of cerebral FTOE (Fractional Tissue Oxygen Extraction) during premedication. FTOE is calculated from rScO2 and pulse oxymetry (SaO2) with the formula FTOE = SaO2 - rScO2/SaO2. Values will be recorded&#xD;
1 minute before the first injection and at 3, 6, 9, 12, 15, 30, 45 and 60 minutes after the first drug injection.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Premedication</condition>
  <condition>Endotracheal Intubation</condition>
  <condition>Cerebral Hypoperfusion</condition>
  <arm_group>
    <arm_group_label>Atropine + propofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Atropine bolus: 20 µg/kg Propofol injected over 60 seconds: 1 mg/kg for infants &lt; 1000g - Renewable once 2.5 mg/kg for infants &gt; 1000G - Possible additional dose of 1 mg/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Atropine + atracurium + sufentanil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Atropine bolus: 20 µg/kg Atracurium: 0.3 mg/kg- Possible additional dose of 0.1 mg/kg Sufentanil: 0.1 µg/kg for infants &lt; 1000g 0.2 µg/kg for infants &gt; 1000g</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>atropine+ propofol</intervention_name>
    <description>Atropine bolus: 20 µg/kg Propofol injected over 60 seconds: 1 mg/kg for infants &lt; 1000g - Renewable once 2.5 mg/kg for infants &gt; 1000G - Possible additional dose of 1 mg/kg</description>
    <arm_group_label>Atropine + propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>atropine + atracurium + sufentanil</intervention_name>
    <description>Atropine bolus: 20 µg/kg Atracurium: 0.3 mg/kg- Possible additional dose of 0.1 mg/kg Sufentanil: 0.1 µg/kg for infants &lt; 1000g 0.2 µg/kg for infants &gt; 1000g</description>
    <arm_group_label>Atropine + atracurium + sufentanil</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Corrected age &lt; 45 weeks of gestational age&#xD;
&#xD;
          -  Currently hospitalized in a neonatal intensive care unit&#xD;
&#xD;
          -  Requiring semi-urgent or elective intubation&#xD;
&#xD;
          -  Equipped with a reliable and permeable IV line&#xD;
&#xD;
          -  Parental consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Lack of parental consent&#xD;
&#xD;
          -  Parental refusal&#xD;
&#xD;
          -  Sedative or anesthetic treatment in the previous 24 hours&#xD;
&#xD;
          -  Hemodynamic compromise defined as mean blood pressure&lt; corrected GA and/or refill time&#xD;
             &gt; 3 seconds&#xD;
&#xD;
          -  Upper airway malformation&#xD;
&#xD;
          -  Life-threatening situation requiring immediate intubation&#xD;
&#xD;
          -  Inclusion in another trial not permitting any other participation&#xD;
&#xD;
          -  Impossibility to establish venous access&#xD;
&#xD;
          -  Any contra-indication to any experimental drug&#xD;
&#xD;
          -  Skin lesions or burns of the forehead&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>28 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Meryl Vedrenne-Cloquet, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHI Créteil</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xavier Durrmeyer, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>CHI Créteil</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital intercommunal de Créteil</name>
      <address>
        <city>Créteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital des enfants</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>https://www.frontiersin.org/articles/10.3389/fped.2019.00040/full</url>
    <description>Open access article</description>
  </link>
  <results_reference>
    <citation>Vedrenne-Cloquet M, Breinig S, Dechartres A, Jung C, Renolleau S, Marchand-Martin L, Durrmeyer X. Cerebral Oxygenation During Neonatal Intubation-Ancillary Study of the Prettineo-Study. Front Pediatr. 2019 Mar 1;7:40. doi: 10.3389/fped.2019.00040. eCollection 2019.</citation>
    <PMID>30881948</PMID>
  </results_reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>March 2, 2016</study_first_submitted>
  <study_first_submitted_qc>March 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2016</study_first_posted>
  <last_update_submitted>August 8, 2019</last_update_submitted>
  <last_update_submitted_qc>August 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Intercommunal Creteil</investigator_affiliation>
    <investigator_full_name>Xavier Durrmeyer</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atropine</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Atracurium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

